Skip to main content
. 2009 Jul 8;2009(3):CD007303. doi: 10.1002/14651858.CD007303.pub2
Two‐stage log‐rank fixed‐effect meta‐analysis Results based on IPD analysis Including additional literature based data
ESA versus control HR (95% CI) HR (95% CI)
Overall survival, all cancer patients 1.06 (1.00‐1.12) 1.06 (1.00‐1.11)
Overall survival, chemotherapy trials 1.04 (0.97‐1.11) 1.04 (0.97‐1.11)